INVIVYD, INC.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $53.4M | $25.4M | $0 |
| Cost of Revenue | — | — | — |
| Gross Profit | — | — | — |
| Gross Margin | — | — | — |
| Operating Expenses | |||
| Research & Development | $38.3M | $137.3M | $158.7M |
| SG&A Expense | $66.9M | $63.4M | $49.1M |
| Operating Income | $-55.6M | $-176.9M | $-212.8M |
| Operating Margin | -104.0% | -696.8% | — |
| Interest Expense | — | — | — |
| Pretax Income | — | — | — |
| Income Tax Expense | $0 | $0 | $0 |
| Net Income | $-52.5M | $-169.9M | $-198.6M |
| Net Margin | -98.2% | -669.4% | — |
| EPS (Basic) | $-0.30 | $-1.43 | $-1.81 |
| EPS (Diluted) | $-0.30 | $-1.43 | $-1.81 |
| Shares Outstanding (Basic) | 172.2M | 118.6M | 109.5M |
| Shares Outstanding (Diluted) | 172.2M | 118.6M | 109.5M |
| Dividends Per Share | — | — | — |